{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:14:19Z","timestamp":1790036059484,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1124\/jpet.116.236075","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T02:03:38Z","timestamp":1469066618000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Unexpected Potency Differences between B-Cell\u2013Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound"],"prefix":"10.1016","volume":"359","author":[{"given":"Amy M.","family":"Nicoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia Hess","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf M.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry L.M.","family":"Ralph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathyadevi","family":"Venkataramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Presky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"DeWire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Brodeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.236075_bib1","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/art.11299","article-title":"Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator","volume":"48","author":"Baker","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"Suppl 4","key":"10.1124\/jpet.116.236075_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar3920","article-title":"B-cell activating factor targeted therapy and lupus","volume":"14","author":"Boneparth","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/jpet.116.236075_bib3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood-2007-09-110874","article-title":"TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts","volume":"111","author":"Bossen","year":"2008","journal-title":"Blood"},{"key":"10.1124\/jpet.116.236075_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1124\/jpet.116.236075_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/eji.201040591","article-title":"Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses","volume":"41","author":"Bossen","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1124\/jpet.116.236075_bib6","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/bi051685o","article-title":"Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor)","volume":"45","author":"Cachero","year":"2006","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.116.236075_bib7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI38010","article-title":"The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus","volume":"119","author":"Cancro","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.236075_bib8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","article-title":"Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases","volume":"44","author":"Cheema","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.116.236075_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/TCRM.S19819","article-title":"New treatment options for lupus: a focus on belimumab","volume":"8","author":"Chiche","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"10.1124\/jpet.116.236075_bib10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni842","article-title":"BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells","volume":"3","author":"Claudio","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.116.236075_bib11","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.116.236075_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sj\u00f6gren\u2019s syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.236075_bib13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","article-title":"TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease","volume":"404","author":"Gross","year":"2000","journal-title":"Nature"},{"key":"10.1124\/jpet.116.236075_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4049\/jimmunol.171.2.761","article-title":"NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells","volume":"171","author":"Hatada","year":"2003","journal-title":"J Immunol"},{"key":"10.1124\/jpet.116.236075_bib15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1006\/jmbi.2001.5296","article-title":"Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes","volume":"315","author":"Karpusas","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1124\/jpet.116.236075_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature01543","article-title":"Ligand-receptor binding revealed by the TNF family member TALL-1","volume":"423","author":"Liu","year":"2003","journal-title":"Nature"},{"key":"10.1124\/jpet.116.236075_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0092-8674(02)00631-1","article-title":"Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands","volume":"108","author":"Liu","year":"2002","journal-title":"Cell"},{"key":"10.1124\/jpet.116.236075_bib18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.yexcr.2011.02.005","article-title":"BAFF inhibition: a new class of drugs for the treatment of autoimmunity","volume":"317","author":"Liu","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1124\/jpet.116.236075_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/jpet.116.236075_bib20","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.116.236075_bib21","first-page":"121","article-title":"Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor","volume":"7","author":"Manetta","year":"2014","journal-title":"J Inflamm Res"},{"key":"10.1124\/jpet.116.236075_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sj\u00f6gren\u2019s syndrome","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1124\/jpet.116.236075_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0960-9822(00)00566-2","article-title":"Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI","volume":"10","author":"Marsters","year":"2000","journal-title":"Curr Biol"},{"key":"10.1124\/jpet.116.236075_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","article-title":"BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator","volume":"285","author":"Moore","year":"1999","journal-title":"Science"},{"key":"10.1124\/jpet.116.236075_bib25","doi-asserted-by":"crossref","first-page":"15978","DOI":"10.1074\/jbc.274.23.15978","article-title":"Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase","volume":"274","author":"Mukhopadhyay","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.236075_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V97.1.198","article-title":"Synthesis and release of B-lymphocyte stimulator from myeloid cells","volume":"97","author":"Nardelli","year":"2001","journal-title":"Blood"},{"key":"10.1124\/jpet.116.236075_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1124\/jpet.116.236075_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","article-title":"B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells","volume":"173","author":"Ng","year":"2004","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"10.1124\/jpet.116.236075_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nsb769","article-title":"Structural basis of BLyS receptor recognition","volume":"9","author":"Oren","year":"2002","journal-title":"Nat Struct Biol"},{"key":"10.1124\/jpet.116.236075_bib30","unstructured":"Ruben SM, Barash SC, Choi GH, Vaughan T, and Hilbert D (2015) inventors, Human Genome Sciences, Inc., assignee. Antibodies that immunospecifically bind to B lymphocyte stimulator protein. U.S. patent 9187548B2. 2015 Nov 15."},{"key":"10.1124\/jpet.116.236075_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.molimm.2013.11.013","article-title":"Contributions of B cells to lupus pathogenesis","volume":"62","author":"Sang","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1124\/jpet.116.236075_bib32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1517\/14712598.2016.1169270","article-title":"Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser","volume":"16","author":"Scheinberg","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"10.1124\/jpet.116.236075_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.coi.2005.04.005","article-title":"The role of APRIL and BAFF in lymphocyte activation","volume":"17","author":"Schneider","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1124\/jpet.116.236075_bib34","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.116.236075_bib35","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","article-title":"Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling","volume":"78","author":"Schuck","year":"2000","journal-title":"Biophys J"},{"key":"10.1124\/jpet.116.236075_bib36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jlb.65.5.680","article-title":"TALL-1 is a novel member of the TNF family that is down-regulated by mitogens","volume":"65","author":"Shu","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1124\/jpet.116.236075_bib37","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.10860","article-title":"Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis","volume":"48","author":"Tan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1124\/jpet.116.236075_bib38","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1126\/science.1061965","article-title":"BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF","volume":"293","author":"Thompson","year":"2001","journal-title":"Science"},{"key":"10.1124\/jpet.116.236075_bib39","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1515\/BC.1999.186","article-title":"Characterization of a new member of the TNF family expressed on antigen presenting cells","volume":"380","author":"Tribouley","year":"1999","journal-title":"Biol Chem"},{"key":"10.1124\/jpet.116.236075_bib40","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.236075_bib41","first-page":"195","article-title":"International nonproprietary names for pharmaceutical substances (INN)","volume":"25","year":"2011","journal-title":"WHO Drug Information"},{"key":"10.1124\/jpet.116.236075_bib42","doi-asserted-by":"crossref","first-page":"35478","DOI":"10.1074\/jbc.M005224200","article-title":"Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS","volume":"275","author":"Wu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.236075_bib43","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0960-9822(01)00481-X","article-title":"Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency","volume":"11","author":"Yan","year":"2001","journal-title":"Curr Biol"},{"key":"10.1124\/jpet.116.236075_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/79802","article-title":"APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity","volume":"1","author":"Yu","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.116.236075_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.166.1.6","article-title":"Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus","volume":"166","author":"Zhang","year":"2001","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"10.1124\/jpet.116.236075_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/427413a","article-title":"TNF ligands: is TALL-1 a trimer or a virus-like cluster?","volume":"427","author":"Zhukovsky","year":"2004","journal-title":"Nature"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524194232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524194232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.236075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:48:57Z","timestamp":1739994537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524194232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0022356524194232"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.236075","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unexpected Potency Differences between B-Cell\u2013Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.236075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}